Northern Trust
LUNG icon

Northern Trust’s Pulmonx LUNG Stock Holding History

Northern Trust’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Sell
104,119
-250,555
-71% -$345K ﹤0.01% 4046
2026
Q1 		$458K Buy
354,674
+17,545
+5% +$29K ﹤0.01% 3647
2025
Q4 		$745K Sell
337,129
-25,242
-7% -$47.5K ﹤0.01% 3505
2025
Q3 		$587K Buy
362,371
+6,773
+2% +$14.2K ﹤0.01% 3596
2025
Q2 		$921K Sell
355,598
-9,304
-3% -$36.7K ﹤0.01% 3441
2025
Q1 		$2.46M Sell
364,902
-7,757
-2% -$54.9K ﹤0.01% 2809
2024
Q4 		$2.53M Buy
372,659
+10,433
+3% +$68.7K ﹤0.01% 2893
2024
Q3 		$3M Buy
362,226
+51,777
+17% +$375K ﹤0.01% 2748
2024
Q2 		$1.97M Sell
310,449
-17,873
-5% -$137K ﹤0.01% 2905
2024
Q1 		$3.04M Sell
328,322
-6,935
-2% -$81.3K ﹤0.01% 2757
2023
Q4 		$4.27M Sell
335,257
-19,066
-5% -$199K ﹤0.01% 2592
2023
Q3 		$3.66M Buy
354,323
+6,593
+2% +$76.4K ﹤0.01% 2623
2023
Q2 		$4.56M Buy
347,730
+26,515
+8% +$324K ﹤0.01% 2556
2023
Q1 		$3.59M Buy
321,215
+4,642
+1% +$45.8K ﹤0.01% 2651
2022
Q4 		$2.67M Buy
316,573
+6,718
+2% +$63.9K ﹤0.01% 2845
2022
Q3 		$5.16M Buy
309,855
+5,445
+2% +$100K ﹤0.01% 2463
2022
Q2 		$4.48M Buy
304,410
+45,684
+18% +$941K ﹤0.01% 2588
2022
Q1 		$6.42M Sell
258,726
-10,348
-4% -$267K ﹤0.01% 2430
2021
Q4 		$8.63M Buy
269,074
+1,768
+0.7% +$64.6K ﹤0.01% 2339
2021
Q3 		$9.62M Buy
267,306
+37,777
+16% +$1.49M ﹤0.01% 2304
2021
Q2 		$10.1M Buy
229,529
+105,917
+86% +$4.61M ﹤0.01% 2353
2021
Q1 		$5.65M Sell
123,612
-8,009
-6% -$459K ﹤0.01% 2673
2020
Q4 		$9.09M Buy
+131,621
New +$6.45M ﹤0.01% 2311

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Northern Trust's LUNG Position: Q2 2026 in Review

Northern Trust reduced its Pulmonx (LUNG) stake by 71% in Q2 2026, selling an estimated $345K and leaving 104,119 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #4046.

Northern Trust first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.1M in Q2 2021. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Northern Trust held 104,119 shares of Pulmonx worth $135K as of Q2 2026.
  • Northern Trust sold 250,555 Pulmonx shares in Q2 2026, an estimated $345K.
  • Pulmonx made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4046 holding.
  • Northern Trust first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • Northern Trust's Pulmonx position peaked at $10.1M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.